Mercy BioAnalytics Selected to Participate in NHS Multicancer Blood Test Trial
STRIDE-RCT will evaluate whether blood tests can help general practitioners identify patients who need urgent investigation for possible cancer WALTHAM, Mass., Nov. 10, 2026 /PRNewswire/ -- Mercy BioAnalytics, Inc. ("Mercy"), a commercial-stage company developing blood-based tests for...